← All peptides
Sexual Health
Cognitive & Nootropic
Research Chemical

OT-9 Amino

Also known as: OT-9 Amino, Oxytocin 9 Amino

A nonapeptide oxytocin variant referring to the nine-amino-acid oxytocin sequence, studied for its roles in bonding, mood, social behavior and reproductive physiology. It is sold as a research-grade analog of native oxytocin.

Last updated

Mechanism of Action

OT-9 Amino corresponds to the nine-residue oxytocin peptide, a cyclic structure with a disulfide bridge. It acts as an agonist at the oxytocin receptor, a G-protein-coupled receptor expressed in the central nervous system and peripheral tissues such as the uterus and mammary glands. Central receptor activation modulates social bonding, trust, anxiety and reward circuitry, while peripheral activation drives uterine contraction and milk ejection. It can also weakly cross-react with vasopressin receptors due to structural similarity.

Half-life
Very short; roughly a few minutes in circulation
Administration Routes
intranasal, subcutaneous
Research Status
Research Chemical

Reported Benefits

  • Studied for social bonding and trust behaviors
  • May reduce anxiety and support mood
  • Investigated for prosocial and empathy-related effects
  • Modulates reproductive and lactation physiology
  • Explored for intimacy and sexual-health research

Potential Side Effects

  • Nausea
  • Headache
  • Changes in blood pressure or heart rate
  • Uterine contractions, relevant in pregnancy
  • Nasal irritation with intranasal use

Common Dosing

Oxytocin research commonly uses intranasal microgram-scale or international-unit dosing; no standardized regimen exists for this analog. Provided for research-use-only context and not as personal medical advice.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Pregnancy, due to uterotonic effects, unless medically supervised
  • Cardiovascular instability
  • Known hypersensitivity to oxytocin or analogs
  • Oxytocin increases trust in humans

    2005

    View
  • Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder

    2021

    View
  • Does intranasal oxytocin reduce symptoms of mental disorders? A meta-analysis of clinical trials

    2026

    View
  • How Relevant is the Systemic Oxytocin Concentration for Human Sexual Behavior? A Systematic Review

    2021

    View

It refers to the nine-amino-acid oxytocin sequence, making it a research-grade analog of the native oxytocin hormone.

Intranasal administration is widely used in oxytocin studies because it is thought to allow better access to central nervous system targets that mediate social and mood effects.

No. Oxytocin and its analogs cause uterine contractions, so use during pregnancy is contraindicated outside of medical supervision.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.